Minoxidil for Beard Growth: What the Trials Actually Show

Five hairs. That is what the first randomised trial of minoxidil for beard growth actually delivered over sixteen weeks, and it beat placebo comfortably. Whether five hairs is worth sixteen weeks of your life is a different question, and it’s the one nobody selling you a beard kit wants to answer.

Beard minoxidil is one of the few areas in hair growth where the internet is ahead of the evidence in volume and behind it in accuracy. There are two proper randomised controlled trials. Both are positive. Both are small. And the single most-recommended add-on, microneedling the face, has never been tested on a beard even once. Here is the whole picture, with the numbers.

The evidence that it works

Start with the trial that started it. In 2016 a Thai group randomised 48 men to minoxidil 3% lotion or placebo, 0.5 mL applied to the chin and jawline twice a day for sixteen weeks. Forty-six finished. Mean beard hair count rose by 5.00 hairs with minoxidil against 0.35 with placebo, a between-group difference of 4.65 with a p value below 0.001.^[1]

Two things about that. It’s unambiguously positive, and it’s published as a two-page letter that reports neither the baseline count nor the size of the counted area. Five hairs out of how many, in how big a patch, is not recoverable. So the direction is solid and the magnitude isn’t interpretable.

The second trial fixed that. In 2026, 69 participants were randomised to 3% minoxidil or placebo for twelve weeks, with density measured properly. Beard density rose 11.16 hairs per square centimetre against 0.08 for placebo. Moustache density rose 18.45 against 1.74. Hair diameter improved too this time, by 5.37 micrometres against a slight loss on placebo. Patient satisfaction was 8.16 against 5.36.^[2]

Note the caveat on that second trial, because it matters. Every participant was a transgender man on stable testosterone therapy. Their follicles were being told to grow by systemic androgens already. A cisgender man with a genetically patchy beard isn’t in the same starting position, and the effect size won’t transfer cleanly.

There is a third piece worth knowing, because of its design. A split-face trial of minoxidil 2% for eyebrows randomised 40 people, 39 completed, and minoxidil beat placebo on all four outcomes.^[3] Split-face means each person was their own control, which removes person-to-person variation entirely. It’s the cleanest design in this literature. Frustratingly, the published abstract reports superiority on every measure without giving a single effect size.

Why it works, which is not what most people think

Minoxidil isn’t a hormone and it doesn’t block anything. It was a blood pressure drug, and the hair growth was the side effect that turned into the product.

Three mechanisms are established. Minoxidil is a prodrug: it must be converted to minoxidil sulfate by the enzyme sulfotransferase inside the follicle before it does anything. Minoxidil sulfate opens ATP-sensitive potassium channels. And the net effect is that follicles are pushed into anagen, the growth phase, early.^[4]

The clearest demonstration of the last one is in rats, and it is startling. Untreated, the third-cycle telogen phase lasted about 20 days. Under minoxidil, follicles re-entered anagen after one to two days of telogen. It shortcuts the resting phase almost completely.

Here is the practical consequence for a beard. Minoxidil doesn’t create follicles you weren’t born with. It recruits existing follicles that are sitting dormant, and it pushes vellus hairs toward terminal. If your patchy area has no follicles in it, nothing happens there. If it has fine, pale, barely-there hairs, that is the territory where minoxidil has something to work with.

Why it does nothing at all for most people

This is the part that gets left out, and it’s the single most useful thing in this article.

Because minoxidil has to be activated by sulfotransferase inside the follicle, how much of that enzyme you have decides whether the drug works. Researchers built an assay for it. Follicular sulfotransferase activity predicted minoxidil response with 95% sensitivity and 73% specificity in a mixed cohort, and the same paper puts overall minoxidil efficacy at 30 to 40% of the population.^[5] A prospective study in women replicated it at 93% sensitivity and 83% specificity.^[6]

This reframes the whole “you must be consistent” advice. Consistency matters, obviously. But a substantial majority of people are not going to respond regardless of how religiously they apply it, and the reason is a fixed enzymatic trait, not effort. Knowing that should change how long you are willing to keep going before you call it.

The shed, on your face

Yes, it happens on beards too, and there is one published record of it that is unusually well controlled for an anecdote. Identical twins, one applying 1.5 grams of 5% minoxidil foam daily to the beard and moustache for sixteen months, the other applying nothing. Genetics held constant. The treated twin noticed new fine hairs at one month, a modest density increase by two months, a shedding episode at around three months, and continued gain after that.^[7]

That sequence is exactly what the mechanism predicts. Minoxidil shortens telogen, so follicles release their club hairs earlier than they otherwise would. Hair falling out is the drug working, not failing.

Worth keeping this in proportion, because the internet oversells it. In the only cohort that counted properly, a shed occurred in 6 of 115 patients starting minoxidil, or 5.2%.^[15] A separate study that measured shedding every four weeks in 49 patients, on the scalp rather than the face, found the increase real but confined to the first twelve weeks.^[14] Most people never shed at all. If you do, it’s unpleasant and it’s temporary. If you don’t, nothing has gone wrong.

What it does that you did not ask for

The same twin case documents the downside: hypertrichosis on the ears and forehead, and increased hair on the chest, abdomen, forearms and legs. From facial application. A separate case report describes diffuse face and ear hypertrichosis on 5% topical minoxidil in a 24-year-old woman, which resolved spontaneously three months after stopping.^[8]

Reversible, then, but real. If you apply minoxidil to your jaw twice a day, some of it will end up on your cheekbones, and cheekbone hair is a common complaint.

Microneedling: the recommendation with no evidence behind it

Every beard guide tells you to roll your face. I went looking for the trials. There aren’t any.

Not thin evidence. Zero. No randomised trial, no case series, not one published case report of microneedling for beard or facial hair growth. The entire recommendation is extrapolated from scalp studies in androgenetic alopecia.

That scalp evidence is real, and it’s worth understanding properly, because the numbers people quote from it are the wrong ones. The landmark 2013 trial randomised 100 men to weekly dermarolling plus 5% minoxidil or minoxidil alone, and reported a mean hair count change of 91.4 per square centimetre against 22.2, with 82% versus 4.5% reporting more than 50% improvement.^[10] A gain of 91 hairs per square centimetre in twelve weeks is not physiologically plausible as true new growth, and the paper reports no standard deviations.

The independent replication is the number to use. In 68 men, combination therapy gained 12.52 hairs per square inch against 1.89 for minoxidil alone, and the authors themselves said the gains were not cosmetically transformative.^[11] That is roughly one seventh of the original effect.

The pooled analysis across twelve randomised trials and 631 patients gives a standardised mean difference of 1.32 for hair count and 0.34 for diameter, both statistically significant. It also found that needle depth, session duration and technique showed no significant differential effect,^[12] which contradicts essentially all consumer protocol advice about going deeper.

Now the part that should give you pause about transferring any of this to your face. Scalp follicles in androgenetic alopecia are being miniaturised by androgens. Beard follicles are stimulated by the same androgens. They respond in opposite directions to the same hormone. Assuming an intervention that helps one will help the other is not a safe assumption, and nobody has tested it.

How to run it, if you run it

If you want to try it, run it properly or don’t run it. Twice a day, every day, sixteen weeks minimum before you judge anything, with a standardised photo on day one under the same light you will use at the end. Most people who conclude it did not work quit at week eight, in the middle of the shed, before the regrowth window opens.

Set the expectation at the trial numbers, not the transformation videos. Eleven hairs per square centimetre is a real change and it is not a new beard. It fills in, it doesn’t create.

On microneedling, I’m not going to tell you it’s useless, because the scalp evidence is decent and the mechanism (Wnt signalling activation was demonstrated in a three-arm trial^[13]) is plausible anywhere skin heals. I’m going to tell you that recommending it for beards is an untested extrapolation, that the meta-analysis says depth doesn’t matter so the deep-needling advice is unsupported, and that facial skin isn’t scalp skin. If you do it, go shallow and infrequent, and understand you are experimenting.

Last thing, and it’s the one I’d want to know. Roughly two thirds of people get little from minoxidil no matter what they do, because of an enzyme they were born with. That figure comes from scalp studies, so I’m extrapolating it to beards, which is the same move I just criticised the microneedling advice for. I think it transfers, because the enzyme is the same enzyme and the drug is the same drug, but you should know I’m reasoning rather than citing. Either way: four months of consistent use that produces nothing isn’t a failure of discipline. It’s an answer.